site:www.clinicaltrialsarena.com - 搜索图片

1038 x 778 · jpeg
www.clinicaltrialsarena.com
Pfizer, BioNTech begin influenza-Covid-19 combinati…
1977 x 1113 · jpeg
www.clinicaltrialsarena.com
eConsent in Clinical Trials: what’s new and what’s yet to come?
1440 x 982 · jpeg
www.clinicaltrialsarena.com
NHS launches personalised mRNA cancer vaccines trial
1440 x 848 · jpeg
www.clinicaltrialsarena.com
LTR Pharma begins recruitment in study of nasal spray for ED

2560 x 1703 · jpeg
www.clinicaltrialsarena.com
ASCO24: Data shows survival benefit with J&J’s subcutaneous …
1440 x 810 · jpeg
www.clinicaltrialsarena.com
Sutro Biopharma begins trial of leukaemia treatment in children
1440 x 960 · jpeg
www.clinicaltrialsarena.com
FDA clears BlueRock’s IND for photoreceptor diseases therapy trial
1440 x 810 · jpeg
www.clinicaltrialsarena.com
First patient dosed in Ankyra's visceral tumour study of ANK-101

1000 x 563 · jpeg
www.clinicaltrialsarena.com
BrioHealth wins FDA nod to trial BrioVAD ventricular assist device
1440 x 810 · jpeg
www.clinicaltrialsarena.com
Oak Hill Bio , Chiesa's OHB-607 trial enrols first European subject
1440 x 810 · jpeg
www.clinicaltrialsarena.com
Damona Pharmaceuticals receives FDA approval for DPX-101 trial

1000 x 465 · jpeg
www.clinicaltrialsarena.com
EADV 2024: Wegovy shows promise in treating common, chronic skin condition - Cli…
1440 x 850 · jpeg
www.clinicaltrialsarena.com
CG Oncology doses first subject in Phase III bladder cancer trial
1000 x 667 · jpeg
www.clinicaltrialsarena.com
Cassava Sciences: Phase III trials storm ahead amid controversy
1000 x 667 · jpeg
www.clinicaltrialsarena.com
ESC 2024: Obicetrapib – a promising breakthrough for dyslip…

834 x 595 · jpeg
www.clinicaltrialsarena.com
The fundamentals of developing parenteral drug products - Clin…
1440 x 810 · jpeg
www.clinicaltrialsarena.com
OncoResponse reports data of Phase I solid tumour treatment trial
1272 x 763 · jpeg
www.clinicaltrialsarena.com
GSK CEO addresses declining trust in vaccines following Trump re-election …
1440 x 810 · jpeg
www.clinicaltrialsarena.com
Minister for Science champions partnerships with private clinical sector i…

1440 x 810 · jpeg
www.clinicaltrialsarena.com
Zymeworks doses first subject in Phase I trial of ZW191
1440 x 810 · jpeg
www.clinicaltrialsarena.com
Ionis announces design for Phase III trial of AS therapy
2560 x 1440 · jpeg
www.clinicaltrialsarena.com
Biofrontera stock climbs as drug-device succeeds in Phase III skin cancer trial

1000 x 563 · jpeg
www.clinicaltrialsarena.com
Newron’s add-on schizophrenia therapy finds success in Phase II/III trial
1000 x 563 · jpeg
www.clinicaltrialsarena.com
ASCO24: AbbVie flexes early success of ADC pipeline in solid tumours
901 x 675 · jpeg
www.clinicaltrialsarena.com
Alzheimer’s disease: major drug trial results to watch in 2022 an…
1260 x 960 · jpeg
www.clinicaltrialsarena.com
Systemic lupus erythematosus: major drug trials to watch in 20…

920 x 517 · jpeg
www.clinicaltrialsarena.com
Novartis’s iptacopan meets primary endpoint in Phase III PNH trial
1835 x 1032 · png
www.clinicaltrialsarena.com
Clash of objectives in academic and commercial trials
1440 x 810 · jpeg
www.clinicaltrialsarena.com
Memo Therapeutics completes enrolment in potravitug trial for BKV

1436 x 852 · jpeg
www.clinicaltrialsarena.com
Eledon reports data from Phase Ib tegoprubart trial
1440 x 960 · jpeg
www.clinicaltrialsarena.com
Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular event…
1440 x 960 · jpeg
www.clinicaltrialsarena.com
ESMO 2023: Pluvicto sees survival hurdle in mCRPC in Novartis’s radio…
1000 x 667 · jpeg
www.clinicaltrialsarena.com
Pfizer meets Phase III primary endpoints for RSV vaccine Abrysvo …

1440 x 825 · jpeg
www.clinicaltrialsarena.com
Targovax announces dosing of first subject with TG01
1440 x 810 · jpeg
www.clinicaltrialsarena.com
VYVGART® for the Treatment of Generalised Myasthenia Gravis

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果